Relationship between testosterone and estradiol levels and lower systemic inflammation after initiation of infliximab treatment in pubertal adolescents with Crohn's disease

Trial Profile

Relationship between testosterone and estradiol levels and lower systemic inflammation after initiation of infliximab treatment in pubertal adolescents with Crohn's disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2015

At a glance

  • Drugs Infliximab (Primary)
  • Indications Crohn's disease
  • Focus Pharmacodynamics
  • Most Recent Events

    • 24 Aug 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top